Literature DB >> 11556978

Identification of a new HLA-DRB1 allele (DRB1*0318) in three members of a Caucasian Spanish family.

M G Ercilla1, A Guardia, B Suárez, M T Arias, V Fabregat, M Costa, I Salinas, J Martorell, J Vives, F Lozano.   

Abstract

This communication reports the identification of a new allele HLA-DRB1*03 in three members of a Caucasian Spanish family. The new allele has been officially named HLA-DRB1*0318 by the World Health Organization Nomenclature Committee. The exon 2 sequence of this new allele is identical to that of DRB1*03011 except for the first nucleotide of codon 45. The nucleotide change (C replacing G) leads to the amino acid substitution of glycine to arginine (GGG-->CGG) at position 45. This position of the beta1 domain shows very little polymorphism among DRB1* alleles (nucleotide changes at this position have only been reported for DRB1*1436 and DRB1*0105) and locates in the vicinity of the highly polymorphic position 47, which is a constituent of the groove's pocket interacting with the amino acid position 7 of the antigen peptide. The familial study showed that the new allele was maternally transmitted into the HLA-A*3002, -B*1801, -Cw*0501, -DRB1*0318, -DRB3*0202, -DQB1*0201 haplotype. Interestingly, the two siblings of the family, which were HLA identical and suffered of insulin-dependent diabetes mellitus (IDDM), were carriers of the two HLA haplotypes (DRB1*03/DQB1*0201 and DRB1*04/DQB1*0302) reported as susceptibility markers to IDDM in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556978     DOI: 10.1034/j.1399-0039.2001.057005489.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  1 in total

1.  Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients.

Authors:  Einas M Al-Harbi; Abdul-Jabbar Abbassi; Hala Tamim; Fayza al-Jenaidi; Mariam Kooheji; Madeeha Kamal; Salwa al-Mahroos; Faisal al-Nasir; Ayesha A Motala; Wassim Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  2004-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.